Becton Dickinson Settles Majority of Hernia Litigation

Becton Dickinson ( (BDX) ) just unveiled an update.

BD (Becton, Dickinson and Company), a prominent medical technology firm, has announced a settlement to resolve the majority of its hernia litigation without admitting liability or wrongdoing. The settlement, accounted for within BD’s existing litigation reserves, will be paid over several years, aligning with the company’s financial strategies and free cash flow objectives. Despite the agreement, BD remains committed to defending itself against unresolved cases and continues to assert the safety and efficacy of its products.

For a thorough assessment of BDX stock, go to TipRanks’ Stock Analysis page.